Pharma news
Americas
Delisting affects a blockbuster narcolepsy drug | Orange book has specific listing criteria | Avadel. 22 December 2022
Americas
Members agreed to a partial waiver of patent protection for COVID-19 vaccines | Latest delay follows a similar decision by the US | WTO accused of “failure”. 20 December 2022
Pharma
Operation took place across Europe | Criminal networks are still exploiting opportunities offered by the COVID-19 pandemic. 20 December 2022
Americas
Lawsuit alleges former employees stole a “treasure trove” of confidential information from three J&J units | Complaint says defendant engaged in a systematic process of hiring Auris staff. 15 December 2022
Americas
As patent attorneys look ahead to 2023's key rulings, Timothy Sendek of Akerman offers insights on the pending enablement case at the Supreme Court. 15 December 2022
Americas
Years-long dispute centred on treatment for gastroesophageal reflux disease | Case invited questions concerning Noerr-Pennington doctrine and immunity | Takeda | Zydus. 13 December 2022
Americas
Two rivals withdrew from acquisition process| Agreement provides access to blockbuster medicines | Janssen Global Services | Sanofi. 13 December 2022
Pharma
Big pharma firm accused of copying technology when developing vaccine | Dispute will also play out in Germany | BioNTech | Moderna. 8 December 2022
Americas
Extension is “pathetic” says vaccine charity coalition | US Trade Representative says extra time will “help the world make a more informed decision” about
the controversial patent waiver. 8 December 2022
Pharma
New addition comes from Fieldfisher | Practice will extend across the US, UK and Continental Europe | renewables and cleantech. 6 December 2022